Patents by Inventor Karl Lenhard Rudolph

Karl Lenhard Rudolph has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NAD-PRECURSORS AND DIETARY RESTRICTION FOR TREATING AGE RELATED MEDICAL CONDITIONS
    Publication number: 20230000888
    Abstract: A nicotinamide adenine dinucleotide (NAD) precursor is provided for use in the treatment and/or prevention of an age-related medical condition in a subject. The NAD precursor is administered in combination with a calorie restriction diet (CRD) and/or a calorie restriction mimetic (CRM). Furthermore, a pharmaceutical combination is provided that includes a NAD precursor and a CRM.
    Type: Application
    Filed: December 18, 2020
    Publication date: January 5, 2023
    Applicant: Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut E.V. (FLI)
    Inventors: Karl Lenhard Rudolph, Elias Amro, Yulin Chen
  • SPECIFIC INHIBITORS OF PROTEIN P21 AS THERAPEUTIC AGENTS
    Publication number: 20150210717
    Abstract: The present invention relates to novel inhibitors of p21. These inhibitors are useful as therapeutic agents for promot ing cell regeneration and in the treatment of cancer. Improvement of cell regeneration is particularly desirable in patients of old age or in patients suffering from chronic diseases, acute or chronic injuries.
    Type: Application
    Filed: September 13, 2013
    Publication date: July 30, 2015
    Inventors: Cagatay Günes, Elena Marita Hoffman, Karl Lenhard Rudolph